Shock Syndromes I
Answer: C
This older adult patient presents with septic shock.
Shock is a syndrome of impaired Do2, leading to tissue
injury and end-organ failure. In this case, it is important
to realize that fever is a symptom of an inflammatory
syndrome, not a shock syndrome (Answers A, B, and
D are incorrect). This patient’s presentation with hypo-
tension, confusion, and hyperlactatemia suggests the
presence of a shock syndrome in the setting of impaired
Do2 (Answer C is correct).
The Fick equation for Do2 best shows Do2. According
to this equation, Do2 depends on CO and Cao2. Cardiac
output depends on heart rate and SV. Typically, an ele-
vated heart rate will increase CO and Do2. However,
if a patient has atrial fibrillation, ventricular filling is
impaired and SV is decreased, causing a decrease in CO
and Do2 (Answer B is correct). Lactate does not impede
Do2 but is a byproduct of impaired Do2 (Answer A is
incorrect). Similarly, Do2 is not impaired by acute kid-
ney injury (Answer C is incorrect). Finally, fever is an
inflammatory response that increases Vo2 but does not
impair Do2 (Answer D is incorrect).
Answer: D
The patient’s laboratory values and arterial pH are
consistent with hyperchloremic metabolic acidosis,
and chloride-rich fluids should be avoided. Lactated
Ringer’s solution is considered a relatively chloride-
poor solution (chloride content 111 mEq/L) and is best
in this case (Answer D is correct). With its chloride
content of 154 mEq/L, 0.9% sodium chloride is consid-
ered a chloride-rich fluid. Liberal use of chloride-rich
fluids such as 0.9% sodium chloride has been associated
with an increased need for renal replacement therapy
(Answer A is incorrect). Although albumin 5% is con-
sidered a chloride-poor solution, data from randomized
controlled trials have not supported a mortality ben-
efit with albumin over crystalloids, even in the setting
of hypoalbuminemia. Moreover, the patient has not
received a “substantial volume” of crystalloids (she has
received less than 30 mL/kg of fluid) that would coin-
cide with recommendations to give albumin (Answer
B is incorrect). Hydroxyethyl starch solutions may also
have a high chloride content (depending on the formula-
tion) and have been associated with an increased need
for renal replacement therapy in the general critical care
population, with no mortality benefit. Hydroxyethyl
starch solutions should be avoided for fluid resuscitation
in the ICU (Answer C is incorrect).
Answer: B
The patient has evidence of end-organ hypoperfusion
(urinary output less than 0.5 mL/kg/hour and elevated
lactate concentration without significant clearance),
despite a MAP greater than 65 mm Hg and quantita-
tive resuscitation. The patient probably needs a higher
perfusion pressure because of a right-shifted zone of
autoregulation secondary to hypertension. The norepi-
nephrine dose should be increased to target a higher
MAP; the exact target will depend on the patient’s
response and should be selected as the threshold that
improves end-organ perfusion (Answer B is correct).
The patient has no evidence of impaired CO (his Scvo2 is
not low); therefore, fluids (to improve SV) and inotropes
(e.g., dobutamine) are not indicated (Answers C and D are
incorrect). Because the patient has continued evidence of
hypoperfusion, action should be taken, and the current
therapy should be modified (Answer A is incorrect).
Answer: B
The patient has hypotension and signs of hypoperfusion
with an elevated lactate concentration; possible inter-
ventions such as fluid administration should be explored
further. Because the patient requires a high Fio2, a reli-
able predictor of fluid responsiveness should be used to
guide fluid therapy instead of administering fluid with-
out respect to predicting responsiveness. In the setting
of atrial fibrillation, an elevated PPV is not a reliable
predictor of fluid responsiveness, and further evaluation
should be done before fluids are administered (Answer
A is incorrect). A PLR test can be used in both spontane-
ously breathing patients and those receiving mechanical
ventilation to predict fluid responsiveness, and the patient
has a method to assess the presence (or absence) of a CO
response (Answer B is correct). Although the accuracy
of the CO value from arterial pulse pressure waveform
analysis may be somewhat limited by atrial fibrillation,
this may be accounted for with the internal software of
most devices and can be used to gauge a response to
the PLR test. The patient has a femoral central venous
catheter, which cannot be used to assess hemodynamic
markers such as CVP or Scvo2 (Answers C and D are
incorrect). Furthermore, CVP is an inadequate predictor
of fluid responsiveness.